Relationship between the Neuroprotective Effect of Na^+/H^+ Exchanger Inhibitor SM-20220 and the Timing of Its Administration in a Transient Middle Cerebral Artery Occlusion Model of Rats
スポンサーリンク
概要
- 論文の詳細を見る
The aim of this study was to determine the relationship between the neuroprotective effect of SM-20220(N-(aminoiminomethyl)-1-methyl-1H-indole-2-carboxamide methanesulfonate)and the timing of its administration in an experimental stroke model. Two hours of occlusion followed by 22h of perfusion of the left middle cerebral artery(MCA)was performed by inserting a nylon thread into the MCA to occlude it, and pulling the thread to initiate reperfusion. Intravenous infusion of SM-20220 for 1h reduced the infarct volume at doses of 0.2-0.8mg/kg in a dose-dependent manner without causing changes in the systemic arterial blood pressure or blood gases, when SM-20220 administration was started 1 h after the onset of occlusion. Administration of SM-20220 at a dose of 0.4mg/kg also reduced the edema formation induced by ischemia. In contrast, SM-20220 failed to reduce the infarction, even at 1.6mg/kg, when administration was started 2h after the onset of occlusion. Thus, the therapeutic time window of SM-20220 for this transient MCA occlusion model is 1h. Daily administration of SM-20220(0.4mg/kg)for the 7d following 1.5h of middle cerebral artery occlusion reduced the infarct volume with statistical significance(p<0.05), showing that SM-20220 did not merely delay but prevented ischemic damage.
- 公益社団法人日本薬学会の論文
- 2001-07-01
著者
-
MATSUI Kouhei
Graduate School of Pharmaceutical Sciences, Osaka University
-
Ohashi N
Discovery Research Laboratories I Research Center Sumitomo Pharmaceuticals Co. Ltd
-
Ohashi N
Sumitomo Pharmaceuticals Research Division
-
Ohashi Naohito
Research Center Sumitomo Pharmaceuticals Co. Ltd
-
Horikawa N
Sumitomo Pharmaceuticals Research Division
-
Matsui Kazuki
Sumitomo Pharmaceuticals Research Division
-
Matsui Kazuki
Research Center Sumitomo Pharmaceuticals Co. Ltd
-
HORIKAWA Naotsugu
Research Division, Sumitomo Pharmaceuticals Co., Ltd.
-
KURIBAYASHI Yoshikazu
Research Division, Sumitomo Pharmaceuticals Co., Ltd.
-
KURIBAYASHI Yoshikazu
Sumitomo Pharmaceuticals Research Division
関連論文
- Sesquiterpene Aminoquinones, from a Marine Sponge, Induce Erythroid Differentiation in Human Chronic Myelogenous Leukemia, K562 Cells
- Structure-Activity Relationships of 3-Methyl and 3,3-Dimethyl Analogs of 2-(2,4-Difluorophenyl)-3-(ω-substituted alkyl)sulfonyl-1-(1H-1,2,4-triazol-1-yl)-2-ipropanols
- Asymmetric Synthesis of SM-9164, a Biologically Active Enantiomer of Antifungal Agent SM-8668
- Sterospecific Actolysis of threo- and erythro-2-Aryl-2-[1-methylthio)ethl]oxiranes
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity
- Synthesis and Biological Activity of N-(Aminoiminomethyl)-1H-indole Carboxamide Derivatives as Na^+/H^+ Exchanger Inhibitors
- Optical Resolution of dl-threo-2-(2,4-Difluorophenyl)-2-[1-(methylthio)ethyl] oxirane: Its Application to the Synthesis of SM-9164, a biologically Active Anantiomer of Antifungal Agent SM-8668
- Protective Effect of SM-19712, a Novel and Potent Endothelin Converting Enzyme Inhibitor, on Ischemic Acute Renal Failure in Rats
- Increase in Vascular Sensitivity to Angiotensin II and Norepinephrine after Four - Day Infusion of 0.3M Sodium Chloride in Conscious Kininogen - Deficient Brown Norway Katholiek Rats
- Pharmacological Characterization of a Novel Sulfonylureid-Pyrazole Derivative, SM-19712, a Potent Nonpeptidic Inhibitor of Endothelin Converting Enzyme
- Design, Synthesis, and Structure-Activity Relationships of 3,4-Dihydropyridopyrimidin-2(1H)-one Derivatives as a Novel Class of Sodium/Calcium Exchanger Inhibitor
- Relationship between the Neuroprotective Effect of Na^+/H^+ Exchanger Inhibitor SM-20220 and the Timing of Its Administration in a Transient Middle Cerebral Artery Occlusion Model of Rats
- Na^+/H^+ Exchange Inhibitor SM-20220 Improves Endothelial Dysfunction Induced by Ischemia-Reperfusion
- Effect of SMP-300, a New Na^+/H^+ Exchange Inhibitor, on Myocardial Ischemia and Experimental Angina Models in Rats
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na^+ Excretion Activity